Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invictus MD Strategies Corp IVITF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Invictus MD Strategies Corp > Germany Deal
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(8)
•••
Comment by gamos99on Sep 24, 2019 8:41pm
202 Views
Post# 30161224

RE:RE:Germany Deal

RE:RE:Germany Deal


I have received this response from connect@invictus-md.com about the status of the five-year supply agreement with Demecan:
Unless a press release is made public regarding updates on the Germany deal I dont have any new information. I have asked my superiors questions regarding Germany and the only answer I get is "will be included in future press releases."

No answer yet from regulatory@demecan.de

I would guess this deal will also be terminated as Trevor "drains the swamp". But we'll see.

Expecting that Q2 2019 earninsg release soon, perhaps this issue will be addressed.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities